Hims & Hers Health, Inc. (HIMS) Financials
Key financial figures for Hims & Hers Health, Inc. (Q2 2026).
Hims & Hers revenue rose 38% year-over-year to $753.2 million in Q2 2026 as subscribers grew to 2.89 million, while gross margin compressed to 64% and the company posted a GAAP net loss of $86.3 million. Revenue of $753.2 million, up 38% year-over-year (Q2 2025: $544.8 million); international revenue grew more than 17-fold following the June close of the Eucalyptus acquisition. Subscribers reached 2.89 million at quarter end, up 19% year-over-year, with Monthly Revenue per Average Subscriber up 21% to $92 from $76. Gross margin was 64% versus 76% a year ago; Adjusted EBITDA was $60.3 million (8% margin) versus $82.2 million (15% margin) in Q2 2025. GAAP net loss was $86.3 million versus net income of $42.5 million a year ago; diluted EPS was $(0.37) versus $0.17. On the outlook: Q3 2026: revenue of $880 million to $900 million and Adjusted EBITDA of $75 million to $95 million (9%-11% margin). Full year 2026 (raised): revenue of $3.1 billion to $3.3 billion and Adjusted EBITDA of $275 million to $325 million (9%-10% margin). Figures are for Q2 2026, as Hims Hers Health Inc. Class A reported them.
- Revenue
- $753M
- Net Income
- -$86M
- EPS
- $-0.37
- Total Assets
- $3.6B
- Operating Cash Flow
- -$36M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $753M | -$86M | -$0.37 | -12.9% | -$55M |
| Q1 FY2026 | $608M | -$92M | -$0.40 | -2.71% | $53M |
| Q4 FY2025 | $618M | $21M | $0.08 | 1.49% | $821K |
| Q3 FY2025 | $599M | $16M | $0.06 | 1.97% | $91M |
| Q2 FY2025 | $545M | $43M | $0.17 | 4.9% | -$69M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $2.3B | $128M | $0.51 | 4.5% | $74M |
| FY2024 | $1.5B | $126M | $0.53 | 4.19% | $198M |
| FY2023 | $872M | -$24M | -$0.11 | -3.38% | $47M |
Frequently asked questions
What was Hims Hers Health Inc. Class A's revenue last quarter?
Hims Hers Health Inc. Class A reported revenue of $753.2 million for Q2 FY2026, up 38.2% from the same period a year earlier.
Is Hims Hers Health Inc. Class A profitable?
Not in its most recent reported period. Hims Hers Health Inc. Class A reported a net loss of $86.3 million for Q2 FY2026, a net margin of -11.46% on revenue.
How has Hims Hers Health Inc. Class A's margin trended?
Operating margin was -12.9% in Q2 FY2026, compared with 4.9% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Hims Hers Health Inc. Class A generate?
Hims Hers Health Inc. Class A generated free cash flow of -$55.4 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Hims & Hers Health, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.